Articles tagged with "brain-computer-interface"
China Approves the First Brain Chips for Sale—and Has a Plan to Dominate the Industry
China has become the first country to approve a commercially available brain implant designed to treat disabilities, marking a significant milestone in neurotechnology. The implant, called NEO and developed by Neuracle Medical Technology, enables individuals with paralysis to control an assistive robotic hand through thought, allowing them to perform basic tasks such as picking up objects and manipulating utensils. After 18 months of safety testing, China's National Medical Products Administration authorized the device for use in people aged 19 to 60 with limb movement impairments. So far, 32 users have tested NEO without adverse side effects. This approval aligns with China's broader strategic plan to dominate the brain-computer interface (BCI) industry within five years. The government recently issued a policy document outlining 17 steps to lead research, development, and application of BCI technologies, emphasizing mass production of non-invasive devices like forehead- or ear-mounted wearables for use in high-risk sectors such as nuclear energy and mining. While brain implants currently focus on restoring
robotbrain-computer-interfaceassistive-technologymedical-implantsroboticsdisability-aidChina-technology-policyRobots tap human instinct to prevent costly mistakes in real time
Researchers at Oklahoma State University are developing a neuroadaptive control system that enables robots to detect and respond to human instinctive error recognition in real time. By using brain-computer interfaces with wearable EEG caps, the system captures error-related potentials (ErrPs)—electrical signals generated in the anterior cingulate cortex when a person perceives a mistake. These signals occur faster than physical reactions, allowing robots to slow down, stop, or return control to the human operator within milliseconds, thereby preventing costly or dangerous errors before they escalate. The system addresses limitations in current teleoperation, where humans remotely guide robots but often react too slowly to sudden failures. An adaptive decoding model personalizes the detection of brain signals to individual users, reducing setup time and increasing practicality. Safety is ensured through Signal Temporal Logic, which enforces strict behavioral constraints on the robot’s actions even when responding to brain signals. Tested with NVIDIA Isaac Lab and RTX PRO 6000 GPUs, this technology has potential applications beyond industrial settings, including healthcare
robotbrain-computer-interfaceneuroadaptive-controlerror-detectionteleoperationsafety-systemsreal-time-processingChina grants world's first commercial approval for brain implant
China’s Neuracle Medical Technology (NMT) has become the first company in the world to receive commercial regulatory approval for a plantable brain-computer interface (BCI) system. Designed to restore motor function in patients with spinal cord injuries, the wireless device is implanted on the brain cortex without penetrating brain tissue, reducing damage risk. It reads neural signals related to movement and converts them into commands to control robotic or prosthetic limbs. This approval marks a significant milestone, transitioning BCIs from experimental research tools to prescribable medical devices, potentially comparable to pacemakers in clinical use. The development reflects China’s strategic push to lead in advanced technologies such as BCIs, artificial intelligence, quantum computing, and biotechnology. By fast-tracking approvals and supporting companies like NMT, China aims to compete with foreign rivals like Elon Musk’s Neuralink. Beyond motor function restoration, BCIs hold promise for treating conditions like ALS, stroke, epilepsy, and Parkinson’s, as well as future applications in speech
robotbrain-computer-interfacemedical-technologyprostheticsneural-implantsassistive-technologywireless-devicesChina clears first commercial brain-computer interface device
China’s National Medical Products Administration has granted the world’s first commercial approval for a brain-computer interface (BCI) device aimed at restoring hand movement in people with paralysis. Developed by Borui Kang Medical Technology, the system assists patients with quadriplegia caused by cervical spinal cord injuries by translating brain signals into commands that control a robotic glove, enabling basic hand grasping. The invasive device uses minimally invasive extradural electrode implantation—placing electrodes outside the dura mater—and wireless communication to capture and transmit neural signals, allowing patients to regain some independence in daily activities. Clinical trials demonstrated significant improvements in hand function, enhancing patients’ quality of life. This approval aligns with China’s strategic emphasis on BCI technology as a priority sector and “future industry” in its latest five-year plan. Experts anticipate rapid advancement and broader public use of BCI technology within three to five years. The development also reflects China’s ambition to compete with U.S. neurotechnology firms like Elon Musk’s Neuralink. The device
roboticsbrain-computer-interfaceassistive-technologyneural-implantswireless-communicationmedical-devicesrehabilitation-technologyScience Corp raises $230M as it races to bring its brain implant to market
Science Corp, founded by Max Hodak, co-founder and former president of Neuralink, has raised $230 million in a Series C funding round, valuing the company at $1.25 billion. The startup is focused on bringing a brain-computer interface (BCI) product to market, specifically through the PRIMA implant, which it acquired from French company Pixium Vision in 2024. Science Corp has refined the technology and completed clinical trials involving 47 patients in Europe and the U.S., with 80% showing meaningful improvement in visual acuity, enabling them to read letters, numbers, and words. Hodak claims this is the first definitive demonstration of restored fluent reading ability in blind patients. The company has submitted a CE mark application for PRIMA in the European Union, anticipating approval by mid-2026, with Germany likely to be the first market due to its established pathways for early access to new medical technologies. Regulatory discussions with the U.S. FDA are ongoing. Science
robotbrain-computer-interfaceneural-implantmedical-technologybiotechneural-engineeringassistive-technologyWhat It’s Like to Have a Brain Implant for 5 Years
Rodney Gorham, a 65-year-old man with ALS who has lost the ability to walk, talk, or move his hands, recently reached a significant milestone by living with Synchron’s brain implant, the Stentrode, for five years. The Stentrode is a minimally invasive device inserted via the jugular vein and positioned against the motor cortex to capture neural signals. These signals are transmitted to an external receiver, enabling Gorham to control digital devices using his thoughts. Over time, Gorham’s control has progressed from simple single clicks to complex two-dimensional cursor movements, demonstrating the implant’s evolving capabilities. Synchron, led by CEO Tom Oxley, is preparing for a larger pivotal trial to seek regulatory approval from the FDA, focusing on defining appropriate clinical endpoints to measure the device’s safety and effectiveness—a challenge unique to brain-computer interfaces. Gorham has played a crucial role in testing new decoding algorithms and interaction methods, contributing to innovations such as Apple’s Switch Control accessibility feature, which allows
robotbrain-computer-interfaceneural-implantsassistive-technologymedical-devicesneurotechnologyhuman-machine-interactionAfter Zomato, Deepinder Goyal returns with a $54M brain-monitoring bet
Indian entrepreneur Deepinder Goyal, co-founder and former CEO of food delivery giant Zomato, has raised $54 million in a friends-and-family funding round for his new wearable startup, Temple. Valued at approximately $190 million post-money, the round included participation from over 30 employees and early Zomato backers. Temple aims to develop a high-performance wearable device designed specifically for elite athletes, featuring a sensor that continuously monitors cerebral blood flow from the wearer’s temple—offering metrics that current wearables like Whoop, Oura, and Garmin do not provide. The startup is aggressively hiring experts in embedded systems, computational neuroscience, and brain–computer interface engineering to build this next-generation device. This move marks a significant pivot for Goyal following his departure from Zomato’s leadership in January after nearly two decades. Temple represents his growing interest in health and performance technology, complementing his other ventures such as Continue Research, which focuses on extending human lifespan, and LAT Aerospace,
wearable-technologybrain-monitoringhealth-techsensorsembedded-systemsbrain-computer-interfaceathletic-performanceChina's origami-inspired brain implant can 'float' on neural tissue
Chinese researchers have developed a novel brain implant inspired by origami and kirigami techniques, designed to be soft, stretchable, and capable of moving with the brain rather than remaining rigid. Traditional brain-computer interfaces (BCIs), such as those by Neuralink, use rigid electrode threads that can shift or retract due to the brain’s natural movements from heartbeat and breathing, leading to reduced signal quality and potential tissue damage. To address this, the Chinese Academy of Sciences team created coil-like, spiral electrode threads that can stretch, compress, and absorb motion, reducing mechanical stress on brain tissue. The implant is also placed on a hydrogel layer to minimize friction and tissue damage, allowing the electrodes to "float" on the brain. Testing on macaque monkeys demonstrated that this origami-inspired BCI could simultaneously record activity from over 700 cortical neurons across a large brain area, maintaining stable recordings with minimal displacement compared to traditional designs. This advancement is significant for BCI applications such as aiding paralyzed
materialsbrain-computer-interfaceorigami-inspired-designneural-implantsflexible-electronicsbiomedical-engineeringneurotechnology7 breakthrough technologies to create next-gen super soldiers
The article outlines seven breakthrough technologies poised to create next-generation super soldiers by enhancing physical strength, situational awareness, and cognitive abilities beyond normal human limits. Key advancements include powered exoskeletons, such as those developed by Sarcos Robotics and DARPA’s Warrior Web, which augment soldiers’ strength and endurance to carry heavier loads with reduced fatigue and injury risk. Augmented reality visors like IVAS integrate thermal imaging, GPS, and tactical data directly into a soldier’s field of view, enabling enhanced navigation and threat detection even in challenging environments. Next-generation body armor employs innovative materials like shear-thickening liquid armor and 3D-printed ceramics to provide superior ballistic protection while maintaining mobility and reducing weight. Further technologies focus on integrating biological and digital enhancements. Brain-computer interfaces, exemplified by DARPA’s N3 program, aim to enable soldiers to control drones and systems through neural signals without invasive surgery, facilitating real-time interaction with multiple digital tools. Biotechnology advances include genetic engineering and engineered microbes
robotaugmented-realitywearable-technologybrain-computer-interfaceadvanced-materialspowered-exoskeletonmilitary-technologyRussian startup turns pigeons into brain-controlled 'living' drones
A Moscow-based startup, Neiry, has developed a neurotechnology project called PJN-1 that implants microscopic electrodes into pigeons’ brains, enabling operators to control their flight paths via electrical impulses. The birds carry lightweight backpacks equipped with controllers, navigation hardware, solar panels, and cameras, allowing real-time GPS tracking and video recording. According to the company, pigeons can fly preset routes and return on command immediately after surgery, without conditioning, and the implantation process reportedly has a 100% survival rate, though this lacks independent verification. The startup argues that pigeons offer advantages over conventional drones, such as longer flight endurance (up to 300 miles per day), ability to navigate complex terrain and tight spaces, and operation in weather or airspace conditions that ground drones. These biodrones could be used for infrastructure inspection, industrial monitoring, power line surveillance, and search and rescue in difficult locations. Neiry plans to expand the technology to other bird species—such as ravens for heavier payloads
robotbrain-computer-interfacebiodronesneurotechnologyenergy-harvestingIoTsurveillance-technologyOpenAI Invests in Sam Altman’s New Brain Tech Startup Merge Labs
OpenAI has invested in Merge Labs, a neurotechnology startup co-founded by OpenAI CEO Sam Altman, aiming to develop brain-computer interfaces (BCIs) that connect human brains to computers using ultrasound technology. Merge Labs has raised $252 million from investors including OpenAI, Bain Capital, and Gabe Newell. Unlike Elon Musk’s Neuralink, which implants electrodes directly into the brain, Merge plans to use non-invasive methods involving molecules and ultrasound to read and modulate neural activity without implants. The company envisions interfaces that integrate biology, devices, and AI to create accessible, user-friendly brain-computer connections. AI will be central to Merge’s approach, with OpenAI collaborating on scientific foundation models to interpret neural signals, adapt to individuals, and improve interface reliability despite noisy data. This could enable more complex brain-computer interactions beyond current capabilities, such as controlling cursors or robotic arms. Merge is a spinoff of Forest Neurotech, a nonprofit focused on brain research, particularly mental
IoTbrain-computer-interfaceneurotechnologyAIultrasound-technologywearable-deviceshuman-computer-interaction7 CES 2026 technologies that make dystopian sci-fi feel oddly practical
At CES 2026, several emerging technologies revealed a trend toward deeply personal and intimate AI devices that blur the line between science fiction and reality. These innovations focus on monitoring and interacting with users in private spaces—such as bathrooms, bedrooms, and even the mind—addressing needs like health tracking, cognitive performance, emotional connection, and memory preservation. While individually these products target familiar wellness or productivity goals, collectively they evoke dystopian sci-fi themes reminiscent of shows like Black Mirror, highlighting how close current technology is to concepts once considered speculative. Key standout technologies include NuraLogix’s Longevity Mirror, a $900 bathroom mirror that uses facial blood flow analysis and AI to predict long-term health risks and physiological aging, turning a daily routine into a constant biological assessment. Neurable and HyperX’s EEG headset tracks brain activity to measure cognitive processing speed and mental fatigue, offering real-time biofeedback to improve focus and reaction times, hinting at future cognitive optimization tools. Vinabot’s AI picture frame
IoTAIhealth-techwearable-devicesbrain-computer-interfacesmart-homebiometric-sensorsNeuralink to scale brain implants, automate surgery, says Elon Musk
Elon Musk announced that Neuralink will scale up to high-volume production of its brain-computer interface devices in 2026, alongside transitioning to an almost fully automated surgical procedure. The implant, designed to aid individuals with conditions like spinal cord injuries, allows users to interact directly with computers. Neuralink began human trials in 2024 after overcoming FDA safety concerns, and as of September, 12 people with severe paralysis have received implants enabling control of digital and physical tools through thought. A notable advancement includes device threads that penetrate the dura mater without removal, simplifying surgery. Additionally, Neuralink plans to initiate trials of its Blindsight implant in 2026, targeting vision restoration for the completely blind by stimulating the visual cortex. Neuralink’s expansion is part of a broader set of ambitious projects Musk’s companies are pursuing in 2026. SpaceX aims to launch its Starship V3 spacecraft with new propulsion capabilities and conduct orbital refueling tests, alongside deploying upgraded Starlink V3 satellites for
robotbrain-computer-interfaceautomated-surgeryneural-implantscognitive-technologymedical-roboticsneural-engineeringIn a first, cerebral palsy patient plays Chinese chess match using BCI
Han Binbin, a cerebral palsy patient with severe motor impairments, made history by competing in a national-level Chinese chess tournament using a non-invasive brain-computer interface (BCI) device. Held in Hainan Province and organized by the Chinese Chess Association, Han faced grandmaster Meng Chen, controlling chess moves solely through his mind via the BCI headset. Previously, Han had to physically nudge chess pieces on a smartphone screen using his nose, a laborious process that limited his ability to fully engage with the game. The BCI technology, which translates EEG brain signals into digital commands, allowed Han to bypass his motor limitations, providing him with a new sense of autonomy and connection to the game. The BCI system used by Han is based on a sophisticated model trained on intracranial EEG data, enabling it to generalize across users and adapt rapidly to different tasks and environments. This breakthrough reflects China’s growing investment in neural technology, exemplified by recent clinical trials at the Shanghai Center
robotbrain-computer-interfaceneural-technologyassistive-technologyEEGroboticssmart-devicesBrain Gear Is the Hot New Wearable
The article highlights the emerging trend of brain-focused wearable devices that use electroencephalography (EEG) to monitor and interpret brain waves, moving beyond traditional fitness trackers. These devices leverage AI to analyze electrical impulses from the brain for various applications, such as improving sleep quality, enhancing productivity, and enabling new forms of interaction. For example, Elemind’s $350 headband uses acoustic stimulation to promote deeper sleep by shifting brain activity to delta waves, while Neurable’s $500 EEG-equipped headphones track concentration levels and encourage breaks to optimize work efficiency. Major tech companies like Apple are also entering the neurotech space, developing EEG-sensing AirPods and integrating brain-wave control into their Vision Pro augmented reality headset, enabling users to operate devices with their thoughts via brain-computer interfaces (BCIs). Additionally, startups and nonprofits are exploring open-source neuro apps and brain-controlled games, demonstrating the potential for brainwave-based interaction in entertainment and productivity. The article also discusses medical applications of brain wearables, such
IoTwearable-technologybrain-computer-interfaceEEG-devicesneurotechnologyaugmented-realityAI-in-healthcareSam Altman’s New Brain Venture, Merge Labs, Will Spin Out of a Nonprofit
Sam Altman, CEO of OpenAI, is launching a new startup called Merge Labs, which is being spun out of the Los Angeles-based nonprofit Forest Neurotech. Merge Labs, still in stealth mode, will focus on developing ultrasound-based brain-computer interfaces (BCIs) to read brain activity. The company’s cofounders include Altman, Forest Neurotech’s CEO Sumner Norman, chief scientific officer Tyson Aflalo, and Alex Blania, CEO of the Altman-backed digital identity company World. Forest Neurotech, founded in 2023 as a focused research organization, has been working on ultrasound BCIs that detect brain activity indirectly by measuring blood flow changes, rather than electrical signals as done by competitors like Neuralink. Forest Neurotech’s ultrasound device is miniaturized from standard ultrasound machines and can also provide brain stimulation through focused sound waves. It is currently being trialed in the UK for safety, with potential applications in treating mental health disorders and brain injuries. One key advantage
robotbrain-computer-interfaceultrasound-technologyneural-engineeringbrain-machine-interfaceneurotechnologymedical-devicesMind control tech becomes real as China moves faster than Elon Musk
Chinese scientists from the Chinese Academy of Sciences have achieved a significant breakthrough in brain-computer interface (BCI) technology by enabling a man with complete paralysis to control smart wheelchairs, robotic dogs, and digital devices solely through brain signals. The patient, Mr. Zhang, who suffered a high-level spinal cord injury in 2022, underwent implantation of a wireless, invasive BCI system called WRS01 at Huashan Hospital in Shanghai. The system uses flexible electrodes implanted in the brain and a processor chip in the skull, communicating wirelessly with an external power and signal receiver. After a few weeks of training, Zhang regained the ability to control a computer cursor and various devices, allowing him to perform paid remote work and navigate physical environments independently. This development marks the first time BCI technology has provided stable, real-world control across multiple robotic platforms, moving beyond laboratory experiments. Zhang’s ability to work remotely as an intern sorter and operate assistive robotics such as a smart wheelchair and robotic dogs demonstrates
robotbrain-computer-interfacewireless-technologysmart-wheelchairrobotic-dogsassistive-technologyneural-implantsNew US-made brain–computer interface runs on one tiny silicon chip
Researchers from Columbia University, New York-Presbyterian Hospital, Stanford University, and the University of Pennsylvania have developed a new brain-computer interface (BCI) platform called the Biological Interface System to Cortex (BISC). This system features an ultra-thin, single-chip implant made from a 50-micrometer-thin CMOS integrated circuit that rests flexibly on the cortical surface. Unlike conventional BCIs that rely on bulky assemblies of multiple components, BISC integrates 65,536 electrodes, 1,024 recording channels, and 16,384 stimulation channels on a single chip with all signal processing, wireless communication, and power management included. The implant wirelessly transmits neural data at speeds up to 100 Mbps—over 100 times faster than comparable devices—via a wearable relay station that also provides power and Wi-Fi connectivity, enabling seamless brain-to-external device communication. The BISC platform is designed to support a wide range of applications, including epilepsy management and restoring motor,
IoTbrain-computer-interfacewireless-communicationsilicon-chipneural-databiomedical-engineeringneuroprostheticsThis startup built a Fitbit for your brain to combat chronic stress
Antonio Forenza, formerly head of R&D at Rakuten Symphony, identified a gap in the consumer health market for a wearable device that tracks stress, similar to how devices like the Apple Watch track physical activity. Leveraging his engineering expertise, he developed Awear, a wearable that uses electroencephalogram (EEG) technology to monitor brain activity—specifically high-frequency beta waves associated with psychological stress. Persistent beta waves can lead to chronic stress, exhaustion, and mental health issues, and Awear aims to help users detect and manage stress proactively before it escalates. Awear, which recently won the health category pitch competition at TechCrunch Disrupt 2025 and is a Startup Battlefield 200 finalist, is currently being tested by Stanford’s psychiatry department for detecting confusion and disorientation in elderly post-surgery patients. However, Forenza’s primary target market is individual consumers, positioning Awear alongside other popular health wearables like the Oura ring. The device is available through an early
IoTwearable-technologybrain-computer-interfaceEEGstress-managementhealth-techconsumer-electronicsAfter Neuralink, Max Hodak is building something stranger
Max Hodak, co-founder and former president of Neuralink, has launched a new venture called Science Corp., aiming to push the boundaries of brain-computer interface (BCI) technology beyond what Neuralink achieved. Drawing on his experience working closely with Elon Musk, Hodak emphasizes innovative engineering breakthroughs—such as creating fully implantable, low-power devices that minimize infection risks—rather than new neuroscience discoveries, which have been ongoing for decades. Science Corp. differentiates itself by generating revenue early through selling affordable research tools and developing a near-term commercial product, rather than relying solely on fundraising. The company’s flagship product, Prima, is a retinal implant smaller than a grain of rice designed to restore “form vision” to people with advanced macular degeneration. Combined with camera-equipped glasses and a portable battery, Prima offers a significant improvement over previous vision restoration technologies. Hodak envisions this as a stepping stone toward more ambitious goals of enhancing human cognition and consciousness through BCI technology. Meanwhile, global interest
robotbrain-computer-interfaceNeuralinkneuroscienceimplantable-deviceslow-power-engineeringtechnology-innovationParadromics Gets FDA Approval to Trial Its Brain Implant in People
Paradromics, an Austin-based brain implant developer, has received FDA approval to begin human trials of its Connexus device, aiming to restore speech for people with severe motor impairments who have lost the ability to speak. The upcoming trial, starting early next year, will initially involve two participants implanted with the device long-term to assess its safety and effectiveness in enabling synthesized speech and text communication. The implant records signals from individual neurons in the brain’s motor cortex, decoding intended speech movements to generate words that can be displayed on a screen and read aloud using AI-generated voice clones, assuming prior voice recordings exist. The Connexus implant is a small metal disk with 421 microwire electrodes that directly interface with brain tissue, allowing for high-bandwidth data transfer between the brain and a computer. Paradromics aims to achieve faster communication speeds, potentially up to 60 words per minute, which is about half the speed of normal speech. This approach contrasts with other brain-computer interfaces (BCIs) like
robotbrain-computer-interfaceneural-implantmedical-devicesAI-voice-synthesisneural-engineeringFDA-approvalCortical Labs' CL1 turns living neurons into programmable processors
Cortical Labs, led by neuroscientist Brett Kagan, has developed the CL1, the world’s first commercial biological computer that uses 800,000 lab-grown human neurons reprogrammed from skin or blood samples to process information. Unlike traditional silicon-based computers, the CL1’s living neurons can learn, adapt, and in some cases outperform machine learning systems. The device, which began shipping in summer 2025 at $35,000 per unit, includes a custom life-support system for the neurons and operates with significantly lower energy consumption compared to conventional data centers. Early users span various fields, including pharmaceutical research, finance, game development, and AI science. The CL1 evolved from an earlier proof-of-concept project called DishBrain, which demonstrated the feasibility of using living neurons for computation by enabling them to play the game Pong. Transitioning from DishBrain to a commercial product required extensive engineering efforts to ensure scalability, reproducibility, and robustness beyond tightly controlled laboratory conditions. Cortical
biological-computingsynthetic-intelligenceneural-networksbrain-computer-interfaceenergy-efficient-computingbiocomputersneuroscience-technologyCortical Labs' CL1 turns living neurons into programmable processors
Cortical Labs, led by neuroscientist Brett Kagan, has developed the CL1, the world’s first commercial biological computer that uses 800,000 lab-grown human neurons reprogrammed from skin or blood samples to process information. Unlike traditional silicon-based processors, these living neurons can learn, adapt, and in some cases outperform machine learning systems. The CL1, priced at $35,000 and shipping since summer 2025, includes a custom life-support system for the neurons and operates with significantly lower energy consumption compared to conventional data centers. Its early adopters span diverse fields such as pharmaceuticals, finance, gaming, and AI research. The journey from the initial scientific proof of concept, DishBrain, to the commercial CL1 product took about two and a half to three years and involved extensive engineering challenges. Moving beyond lab-scale experiments required building a scalable, reproducible system, which meant developing everything from low-level code and kernel-level software to custom hardware including FPGAs and printed
biological-computingsynthetic-intelligenceneural-networksbrain-computer-interfaceenergy-efficient-computingregenerative-medicineAI-researchNeuralink's breakthrough lets patient control robot with thoughts
Neuralink has achieved a significant breakthrough in brain-computer interface technology by enabling an amyotrophic lateral sclerosis (ALS) patient, Nick Wray, to control a robotic arm using only his thoughts. Through an implanted brain chip, Wray was able to perform everyday tasks such as microwaving food, drinking from a cup, opening a refrigerator, and even maneuvering his wheelchair. This milestone was demonstrated during the FDA-approved “CONVOY” study, which aims to restore independence for people with severe mobility impairments by translating neural signals into Bluetooth commands that control external devices. The implant, called the N1 chip, is a small device equipped with 128 ultra-fine threads containing about 1,000 electrodes that connect directly to the brain’s surface. These electrodes detect neural activity and convert it into precise digital commands. Neuralink began human trials in 2024 after overcoming initial FDA safety concerns. Eight participants have received the implant so far, including the first recipient, Noland Arbaugh
robotbrain-computer-interfaceNeuralinkassistive-technologymedical-roboticsbrain-implantrobotic-arm-controlThis Startup Wants to Put Its Brain-Computer Interface in the Apple Vision Pro
Startup Cognixion is launching a clinical trial to integrate its noninvasive brain-computer interface (BCI) technology with Apple’s Vision Pro headset to help paralyzed individuals with speech impairments communicate using their thoughts. Unlike implant-based BCIs from companies like Neuralink, Cognixion’s system uses a custom headband equipped with six EEG sensors that detect brain signals related to visual fixation, enabling users to select options via mental attention. The trial will involve up to 10 participants in the US with speech disorders caused by conditions such as spinal cord injury, stroke, traumatic brain injury, or ALS. Cognixion’s technology combines hardware with AI-driven software that customizes communication models based on each user’s speech history and patterns, allowing for near-normal conversation speeds. Previously tested with ALS patients using their own Axon-R headset, the company now aims to leverage the broader functionality and app ecosystem of the Vision Pro to democratize access to BCI communication tools. Cognixion’s approach focuses
robotbrain-computer-interfacewearable-technologyassistive-technologyaugmented-realityAI-communicationmedical-devicesHow BrainCo robotic hands are changing lives - The Robot Report
BrainCo, a company founded in 2015 and incubated by Harvard Innovation Lab, has developed an advanced non-invasive brain-computer interface (BCI) that enables users to control prosthetic hands with remarkable dexterity. The technology notably transformed the life of Jian, a teenager who lost his right arm in an accident. Using BrainCo’s Intelligent Bionic Hand, Jian regained the ability to perform complex tasks such as rock climbing and playing the piano, restoring both his physical capabilities and his sense of hope. The company’s latest product, the Revo 2 Dexterous Hand, is a lightweight (383 g) prosthetic capable of generating a grip force of 50 newtons, allowing it to lift up to 20 kg. It features biomimetic joint optimization, precision transmission, and a 3D tactile sensing system that can perceive hardness, texture, force direction, and distance, enabling delicate tasks like lighting a match. The device operates quietly (below 50 decibels)
robotroboticsprostheticsbrain-computer-interfacebionic-handhumanoid-robotstactile-sensingNeuralink performs first-ever brain implant surgeries in Canada
Neuralink has successfully performed its first brain-computer interface implant surgeries in Canada, marking a significant expansion of its clinical trials beyond the United States and the United Kingdom. Two patients with cervical spinal cord injuries underwent robotic-assisted implantation of Neuralink’s wireless brain device at the University Health Network (UHN) in Toronto as part of the CAN-PRIME Study. This study aims to assess the safety of the implant and surgical robot, and to determine whether individuals with paralysis can use their thoughts to control external devices such as cursors, text messaging, or robotic arms. Recruitment for the study is ongoing, including patients with cervical spinal injuries or amyotrophic lateral sclerosis (ALS). The implants hold promise for dramatically improving the quality of life for people with paralysis by enabling them to perform everyday tasks like checking emails or using smart home devices through thought control. The surgeries underscore Canada’s growing prominence in neurotechnology research, with UHN recognized as a leading center for surgical innovation. Neuralink, founded by Elon
robotbrain-computer-interfaceneural-implantsneurotechnologyrobotic-surgeryassistive-technologywireless-devicesNeuralink’s Bid to Trademark ‘Telepathy’ and ‘Telekinesis’ Faces Legal Issues
Neuralink, the brain implant company co-founded by Elon Musk, has encountered legal challenges in its attempt to trademark the terms "Telepathy" and "Telekinesis." The United States Patent and Trademark Office (USPTO) rejected Neuralink’s applications due to prior filings by Wesley Berry, a computer scientist and co-founder of tech startup Prophetic, who submitted trademark applications for "Telepathy" in May 2023 and "Telekinesis" in August 2024. Berry’s applications, filed as “intent-to-use,” describe software analyzing EEG data to decode internal dialogue for device control, though he has not yet commercialized products under these names. Additionally, the USPTO cited an existing trademark for Telepathy Labs, a company offering voice and chatbot technology, in its refusal to advance Neuralink’s application for "Telepathy." Neuralink has been using the name "Telepathy" for its brain implant product designed to enable paralyzed individuals to operate phones and computers via thought.
robotbrain-computer-interfaceneural-implantswearable-technologyEEG-analysisassistive-technologyhuman-machine-interactionAI brain interface lets users move robot arm with pure thought
Researchers at the University of California, Los Angeles (UCLA) have developed a new wearable, noninvasive brain-computer interface (BCI) system that uses artificial intelligence (AI) to help individuals with physical disabilities control robotic arms or computer cursors through thought. Unlike previous BCI devices that required invasive neurosurgery, this system combines an electroencephalography (EEG) cap with a camera-based AI platform to decode brain signals and interpret user intent in real time. The AI acts as a “co-pilot,” enhancing the user’s control by guiding actions such as moving objects, thereby offering a safer and more practical alternative for people with paralysis or neurological disorders. In trials involving four participants—including one paralyzed individual—the AI-assisted system enabled faster and more accurate task completion, such as moving a cursor to targets and manipulating blocks with a robotic arm. Notably, the paralyzed participant was able to complete a robotic arm “pick-and-place” task in about six and a half minutes
roboticsbrain-computer-interfaceartificial-intelligenceassistive-technologywearable-technologyneural-engineeringrobotic-arm-controlChina Is Building a Brain-Computer Interface Industry
China has unveiled an ambitious policy roadmap aiming to establish itself as a global leader in brain-computer interface (BCI) technology by 2030, with breakthroughs targeted by 2027. BCIs, which decode neural activity to control external devices, hold significant promise for assisting people with severe physical disabilities. The policy, jointly issued by seven Chinese government departments, outlines 17 specific steps including developing advanced brain signal chips, improving decoding software, standardizing technology, and building manufacturing capacity. This initiative reflects China’s broader strength in rapidly translating research into commercial products, as seen in other sectors like photovoltaics and electric vehicles. Although BCI research began in the 1970s, practical applications have only recently become feasible due to technological advances. China entered the field later than the US but is quickly closing the gap. Chinese companies and research institutions have successfully implanted BCIs in paralyzed patients, enabling them to control computer cursors, robotic arms, and even decode speech. For example, Shanghai-based Neuro
robotbrain-computer-interfaceneuralinkassistive-technologyneuroengineeringChina-technology-policyBCI-developmentWoman regains speech 18 years after stroke with brain implant
Eighteen years after suffering a brainstem stroke that left her with locked-in syndrome and near-total paralysis, Ann Johnson regained the ability to speak through an AI-powered brain-computer interface (BCI). The implant, placed over her brain’s speech motor cortex, detects neural signals when she attempts to speak and translates them via an AI decoder into audible words and facial animations on a digital avatar. Initially, the system had an eight-second delay due to sentence-based processing, but recent advances reported in 2025 have reduced this latency to about one second using a streaming AI architecture, enabling near-real-time communication. Johnson’s voice was personalized using recordings from her 2004 wedding speech, and she selected an avatar that mimics her facial expressions. The clinical trial, led by researchers at UC Berkeley and UCSF, aims to transform neuroprostheses from experimental devices into practical, plug-and-play clinical tools. Future developments may include wireless implants and photorealistic avatars to enhance natural interaction. The technology
robotAIbrain-computer-interfaceneuroprostheticsmedical-technologyspeech-restorationassistive-technologySam Altman reportedly plans brain chip startup to rival Elon Musk
Sam Altman, CEO of OpenAI, is reportedly planning to launch a brain-chip startup called Merge Labs to compete directly with Elon Musk’s Neuralink, according to a Financial Times report. Merge Labs aims to develop advanced brain-computer interfaces (BCIs) that merge humans and machines through artificial intelligence. Valued at $850 million, the startup seeks to raise $250 million in funding, primarily from OpenAI’s ventures team. Altman is expected to co-found the company alongside Alex Blania, CEO of Worldcoin, another OpenAI-backed firm, though Altman himself will not be a personal investor. The initiative is still in early stages, and OpenAI has not finalized its commitment. Neuralink, founded in 2016, currently leads the implantable BCI market and has already begun human trials, notably helping ALS patient Bradford G. Smith communicate via thought-controlled computer cursors. Musk plans to scale Neuralink’s implants to 20,000 people annually by 2031
robotbrain-computer-interfaceneuralinkartificial-intelligencebrain-chiphuman-machine-integrationbiotechNeuralink brain chip trials launch in Britain for paralyzed patients
Neuralink, Elon Musk’s brain-implant company, has initiated its first European clinical trial in the UK, aiming to test its brain-computer interface (BCI) technology on seven patients with severe paralysis caused by spinal cord injuries or neurological conditions like ALS. The trial, conducted in partnership with University College London Hospitals NHS Foundation Trust and Newcastle upon Tyne Hospitals, involves implanting Neuralink’s N1 chip under the skull to enable patients to control digital devices such as smartphones and tablets using only their thoughts. This marks the UK as the first European country to host such a study and builds on Neuralink’s earlier human trials in the US, where five paralyzed patients have already used the chip to operate devices mentally. Neuralink’s N1 chip is a small device, about the size of a 10-pence coin, equipped with 128 ultra-thin threads that connect approximately 1,000 electrodes to the brain to read electrical activity and translate it into digital commands. The company
robotIoTbrain-computer-interfaceNeuralinkmedical-technologyassistive-technologyneurotechnologyNeuralink helps paralysed woman write her name after 20 years
Audrey Crews, a woman paralyzed for over 20 years, has successfully written her name using only her mind, thanks to Elon Musk’s Neuralink brain-computer interface (BCI) technology. Crews, who lost movement at age 16, is the first woman to receive the Neuralink implant, which involves brain surgery to insert 128 threads into her motor cortex. The chip, about the size of a quarter, enables her to control a computer purely through brain signals, marking a significant milestone in BCI development. However, Crews clarified that the implant does not restore physical mobility but is designed solely for telepathic control of digital devices. Neuralink’s PRIME Study, which tests these implants in human subjects, includes other participants such as Nick Wray, who also shared positive early experiences with the technology. Wray, living with ALS, expressed hope and excitement about the potential for digital autonomy and the future impact of BCIs. Founded in 2016, Neural
robotbrain-computer-interfaceNeuralinkassistive-technologymedical-implanthuman-machine-interactionneurotechnologyThe Very Real Case for Brain-Computer Implants
The article discusses the emerging and rapidly advancing technology of brain-computer interfaces (BCIs), focusing on the competitive efforts of companies like Synchron to develop commercial implants that enable direct communication between the human brain and digital devices. These implants allow users to control computers or phones through thought alone, a concept once confined to science fiction but now becoming a tangible reality. The piece highlights the significance of this technology in Silicon Valley's tech landscape and its potential to transform human-computer interaction. Additionally, the content is drawn from an episode of WIRED’s podcast "Uncanny Valley," where hosts and guests explore the implications, challenges, and progress in the BCI field. While the transcript includes casual conversation and podcast logistics, the core takeaway centers on the promise and ongoing development of brain implants as a groundbreaking interface technology, underscoring a heated race among companies to bring effective, user-friendly BCIs to market. However, the article’s transcript is incomplete and somewhat fragmented, limiting detailed insights into technical specifics or broader
brain-computer-interfaceneurotechnologybiomedical-implantshuman-machine-interactionneural-implantsbrain-computer-communicationmedical-technologyThere's Neuralink—and There's the Mind-Reading Company That Might Surpass It
The article contrasts two brain-computer interface (BCI) technologies aimed at helping people with paralysis regain autonomy: Elon Musk’s Neuralink and the startup Synchron. Unlike Neuralink, which requires invasive open-skull brain surgery, Synchron’s BCI is implanted via a less invasive procedure through blood vessels, avoiding direct brain surgery. The article follows Mark Jackson, a 65-year-old man with ALS (amyotrophic lateral sclerosis), who uses Synchron’s implant to control a computer game with his thoughts. Despite his paralysis, Jackson can steer a cursor by thinking about specific hand movements, demonstrating how the system decodes neural signals linked to intended actions using AI-powered software. Jackson’s journey highlights the potential of Synchron’s technology to restore independence for people with neurodegenerative diseases. After a multi-hour implantation procedure and months of calibration, Jackson successfully connected the internal implant with an external unit, enabling him to interact with digital devices through thought alone. While the implant does not slow ALS progression, it offers a new
robotbrain-computer-interfaceneural-technologyassistive-technologymedical-devicesneurotechnologyALS-treatmentRobotic hand moves like magic, controlled by nothing but thought
Researchers at Carnegie Mellon University have achieved a breakthrough in noninvasive brain-computer interface (BCI) technology by enabling real-time control of a robotic hand’s individual fingers using only human thought. Utilizing electroencephalography (EEG) combined with a novel deep-learning decoding strategy, the system translates brain signals into precise finger movements without any muscle activity. Volunteers successfully performed multi-finger tasks, demonstrating the system’s ability to overcome traditional EEG spatial limitations and achieve fine motor control. Led by Professor Bin He, whose lab has pioneered several EEG-powered robotic controls, this innovation offers a risk-free, external alternative to invasive BCIs that require surgery. The technology holds significant promise for a broad range of users, including people with motor impairments or those recovering from injuries, by enhancing hand function and quality of life. Beyond medical rehabilitation, the system’s natural dexterity opens possibilities for everyday tasks like typing or manipulating small objects, potentially redefining how assistive devices integrate seamlessly as intuitive extensions of the human body
roboticsbrain-computer-interfacenoninvasive-BCIdeep-learningprostheticsassistive-technologyEEG-controlChina: Paralyzed patient regains limb function with new brain-chip
A research team led by Professor Duan Feng at Nankai University in China has conducted the world’s first human trial of a brain-computer interface (BCI) implanted via blood vessels, enabling a 67-year-old stroke patient with hemiplegia to regain voluntary limb movement. Unlike more invasive methods such as Elon Musk’s Neuralink, this minimally invasive procedure involved inserting a stent electrode with 50-micrometre thick electrodes into the patient’s brain blood vessels through a vein in the neck. The electrodes connect wirelessly to an implanted device, allowing real-time EEG signal transmission and functional electrical stimulation that supports motor training and neuroplasticity. Following treatment, the patient regained the ability to grasp objects and perform daily tasks without side effects like infection or thrombosis. This breakthrough builds on prior animal studies where BCIs controlled movements in sheep and monkeys, marking a significant advancement in interventional BCI surgery. The Chinese trial demonstrates not only the safety and efficacy of this minimally invasive approach but
brain-computer-interfaceroboticsneurotechnologymedical-devicesfunctional-electrical-stimulationwireless-implantsstroke-rehabilitationChina tests neural implant that lets amputee to move cursor with mind
Chinese researchers have successfully tested an advanced invasive brain-computer interface (BCI) implant that enables a 37-year-old quadruple amputee to control a computer cursor with his mind. The implant, a coin-sized device with ultra-small, flexible electrodes developed by the Chinese Academy of Sciences (CAS), was implanted into the patient’s motor cortex. Within weeks, he was able to perform tasks such as playing chess and gaming with near-normal skill. The electrode is notable for being about one-fifth the thickness of Neuralink’s electrodes and highly flexible, minimizing tissue disruption and immune rejection. The implant underwent extensive preclinical testing on mice and macaques before human trials began. The surgical procedure took less than 30 minutes, using advanced 3D brain mapping and real-time navigation to ensure precise placement. Moving forward, the research team plans to expand trials to include up to 40 patients with paralysis or ALS by 2026. Future phases will focus on training participants to control robotic arms for practical tasks
robotbrain-computer-interfaceneural-implantmedical-roboticsbrain-machine-interfaceassistive-technologyneural-electrodesNew brain-computer tech lets paralyzed patient talk in real time
A new investigational brain-computer interface (BCI) developed by researchers at the University of California, Davis, has enabled a paralyzed patient with Amyotrophic Lateral Sclerosis (ALS) to communicate in real time using a synthesized version of his own voice. ALS causes loss of muscle control, including speech, making communication difficult or impossible. This BCI system uses surgically implanted microelectrode arrays in the brain’s speech region to capture neural activity, which is then decoded by advanced AI algorithms to produce near-instantaneous audible speech. The technology significantly reduces the delay seen in previous speech neuroprostheses, allowing for more natural, spontaneous conversations with a delay as low as one-fortieth of a second. The system was tested on a 45-year-old participant in the BrainGate2 clinical trial, who was asked to attempt speaking sentences displayed on a screen while his brain activity was recorded. The AI model mapped his neural firing patterns to intended speech sounds, enabling the participant to control
robotbrain-computer-interfaceneuroprostheticsreal-time-voice-synthesismicroelectrode-arraysassistive-technologyparalysis-communicationA Neuralink Rival Just Tested a Brain Implant in a Person
Paradromics, an Austin-based neurotechnology company founded in 2015, has conducted its first human test of Connexus, a brain implant designed to restore speech and communication in people with paralysis caused by spinal cord injury, stroke, or ALS. The device translates neural signals into synthesized speech, text, and cursor control by recording electrical activity from individual neurons via 420 tiny electrodes embedded in the brain tissue. The initial human implantation occurred on May 14 at the University of Michigan during epilepsy surgery, where the device was temporarily inserted into the temporal lobe using a specialized EpiPen-like tool. This procedure allowed researchers to confirm the device’s ability to capture neural signals with high resolution, which is critical for accurately decoding intended speech. Connexus is part of a growing field of brain-computer interface (BCI) technologies, including Elon Musk’s Neuralink and Synchron, which also develop implants to interpret neural signals but differ in electrode design and signal resolution. Unlike other devices that record from groups of neurons, Paradromics’ implant targets individual neurons to achieve higher-quality signals. BCIs do not read private thoughts but decode neural patterns associated with intended movements, such as facial muscle activity involved in speech. Recent studies from Stanford and UC San Francisco have demonstrated the ability to decode intended speech at rates approaching half of normal speaking speed in paralyzed individuals. Paradromics aims to launch a clinical trial by the end of 2023 to implant Connexus long-term in patients with paralysis, advancing toward commercial availability despite the regulatory and technical challenges of fully implantable brain devices.
robotbrain-computer-interfaceneural-implantsmedical-devicesneurotechnologyassistive-technologybiomedical-engineeringChip não giúp chỉnh sửa video và đăng YouTube bằng suy nghĩ
robotIoTNeuralinkbrain-computer-interfaceassistive-technologyAIALS